BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 12870169)

  • 1. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
    Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
    Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.
    Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
    Metabolism; 1999 Apr; 48(4):511-9. PubMed ID: 10206447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance.
    Goldenberg N; Glueck CJ; Loftspring M; Sherman A; Wang P
    Metabolism; 2005 Jan; 54(1):113-21. PubMed ID: 15562389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
    Ehrmann DA; Liljenquist DR; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):48-53. PubMed ID: 16249284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome.
    Cheang KI; Huszar JM; Best AM; Sharma S; Essah PA; Nestler JE
    Diab Vasc Dis Res; 2009 Apr; 6(2):110-9. PubMed ID: 20368201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome.
    Marchesan LB; Spritzer PM
    Fertil Steril; 2019 Mar; 111(3):579-587.e1. PubMed ID: 30827526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can metformin reduce insulin resistance in polycystic ovary syndrome?
    Açbay O; Gündoğdu S
    Fertil Steril; 1996 May; 65(5):946-9. PubMed ID: 8612854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level.
    Dewailly D; Contestin M; Gallo C; Catteau-Jonard S
    BJOG; 2010 Jan; 117(2):175-80. PubMed ID: 19832825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
    Song do K; Lee H; Sung YA; Oh JY
    Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan.
    Hammad EA; Yasein N; Tahaineh L; Albsoul-Younes AM
    J Manag Care Pharm; 2011 May; 17(4):295-303. PubMed ID: 21534640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
    Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
    Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
    Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
    J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.